Educational only — not medical advice. Pepathary never recommends a medication or a dose, and never sells anything. The safest path to a GLP-1 is an FDA-approved drug, prescribed by a licensed clinician and filled at a licensed pharmacy. Talk to your doctor before you start, stop or change anything — and get a prescription where one is required.
Semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro) are everywhere right now. The good news for newcomers: as of mid-2026 the safest, FDA-approved paths got cheaper, while the unregulated ones got both riskier and more legally exposed. Here is how the landscape actually works.
Free reconstitution calculator
If you draw a GLP-1 from a vial, the #1 documented error is a mix-up between mg and mcg (1 mg = 1000 mcg), which can cause a 10× or 100× overdose. This shows your draw in units, mL and mg side by side so you can double-check. It’s mixing math — not a dose recommendation.
This calculator runs entirely in your browser. It is a concentration-math utility, not medical advice, and it does not recommend a dose — you enter the dose. Always confirm every result and follow your physician’s instructions.
The journey, stage by stage
1 · Deciding & talking to a doctor
Weigh the benefits, side effects and cost, and get evaluated by a clinician who reviews your history (thyroid C-cell tumor / MEN2, pancreatitis, gallbladder, pregnancy plans, other meds). The label-indicated path is an FDA-approved brand from a licensed pharmacy.2 · Starting dose (the on-ramp)
Treatment begins low to let the gut adapt — not to drive maximal loss. Per the labels, Wegovy starts at 0.25 mg/week and Zepbound at 2.5 mg/week, usually held ~4 weeks. The exact dose comes from your prescriber and the label.3 · Titration (start low, go slow)
Doses step up gradually, generally no faster than every 4 weeks and only if tolerated. There is no requirement to reach the top dose — the goal is the lowest effective dose with tolerable side effects.4 · Side-effect weeks
Nausea, reflux, constipation/diarrhea and fatigue are most common in the first 1–4 weeks and after each dose bump, then usually ease. Severe or persistent symptoms mean call your clinician, not push through.5 · Plateau & maintenance
Weight loss naturally slows at a new equilibrium — a plateau is expected, not failure. Stopping abruptly leads most people to regain much of the loss, so continuing, lowering or stopping is a clinician-guided decision.How people get GLP-1s — and the risks
Ranked safest first. This describes the landscape and the risks — it is not a how-to-buy guide and does not endorse any non-approved path.
Branded FDA-approved Rx + insurance / savings card Safest
Cost: ~$25/mo with commercial insurance + a maker savings card; ~$1,000+/mo list without coverage (mid-2026).
Legality: FDA-approved — the standard, regulated path.
Risks: Lowest — verified molecule, dose, device, plus pharmacist + physician oversight. The drugs still carry real side effects (nausea, pancreatitis, gallbladder, dehydration/kidney, a thyroid-tumor boxed warning), which is why supervision matters.
Manufacturer cash / self-pay vials (LillyDirect, NovoCare) Safest
Cost: ~$299–$449/mo (Zepbound vials), ~$349/mo (Wegovy self-pay) as of late-2025 cuts; intro offers expire — confirm current terms.
Legality: FDA-approved real brand from the maker; requires a valid prescription.
Risks: Same low risk; vials mean you draw the dose yourself, so get shown how to measure.
Telehealth cash subscriptions Moderate
Cost: ~$99–$550/mo depending on branded vs compounded and level of care.
Legality: Telehealth prescribing is legal; branded = FDA-approved; compounded sits in the restricted/contested zone (drew FDA warning letters for misleading marketing).
Risks: Quality varies a lot. Async-only with no labs or follow-up is weak oversight — riskier if you take other meds.
503A / 503B compounded Higher risk
Cost: Historically ~$150–$400/mo; availability dropped sharply in 2026.
Legality: Largely NOT permitted as a routine product now that shortages resolved (503A discretion ended Feb/Apr 2025, 503B by May 2025; FDA proposed Apr 2026 to bar these from the 503B bulks list). A narrow 503A exception needs a documented individual medical need — cost alone doesn’t qualify.
Risks: Not FDA-reviewed for safety/quality; hundreds of adverse-event reports tied to compounded GLP-1s; self-measured vial dosing errors have caused overdoses.
Gray-market “research” / peptide-vendor vials Highest risk
Cost: Often the cheapest sticker price — which is the lure, not a bargain; it reflects zero oversight.
Legality: Not legal as medicine. Sold under a “research only / not for human use” loophole the FDA is actively closing (dozens of warning letters across 2025–2026, plus public warnings). Described here only so you know the path exists and why it is dangerous — it is not endorsed.
Risks: No verification of identity, purity, sterility or dose; independent testing has repeatedly found mislabeled, contaminated or mis-dosed product. Infection and overdose risk, zero medical oversight.
Saving money — safely
- Use insurance and appeal a denial. Get the reason in writing; have your doctor send a medical-necessity letter. Can take $1,000+/mo to a $25–$100 copay. Risk: paperwork; weight-loss coverage is inconsistent.
- Manufacturer savings card (branded drug) → about $25/mo. Risk: commercial insurance only (not Medicare/Medicaid/VA/TRICARE); caps + expiration.
- Manufacturer self-pay vials (FDA-approved, not compounding) → ~$199–$449/mo vs $1,000+ retail. Risk: still a real cost; you self-inject from a vial.
- Medicare options: a demonstration offering about $50/mo for eligible beneficiaries has been announced (starting mid-2026). Risk: time-limited, eligibility rules — confirm with CMS / your plan.
- Vial vs pen: vials are usually cheaper. Risk: vials remove the pen’s dose stops — higher chance of measuring wrong.
- Dose-splitting / microdosing: do not do this on your own — not evidence-based, raises contamination risk, can reduce benefit, and self-adjusting a dose can be unsafe. Only under a clinician.
Prices are as of mid-2026 and change often — confirm current terms with the pharmacy, manufacturer, or your plan.
Safety-first checklist
- Talk to a doctor first and get a prescription where required.
- Verify any source is a licensed pharmacy (verifiable name, US state license, real prescriber review; LegitScript / PCAB / NABP). Red flags: no name/license/prescriber, crypto or gift-card payment, “no prescription needed.”
- A Certificate of Analysis reduces but does not eliminate risk — it can be faked, may test a different batch, and never makes an unapproved product safe.
- Reconstitution + dual-unit dosing is the #1 error source — confirm mg, mL and units together (use the calculator above).
- Storage per label (fridge, not freezer); never share pens/needles; use a sharps container.
- Discuss contraindications with your doctor (pregnancy/trying to conceive, personal/family medullary thyroid cancer or MEN2, pancreatitis, gallbladder, insulin/sulfonylurea interactions). Don’t start, stop or change a dose on your own.
Track it all — free, private, on your device.
Pepathary keeps your reminders, titration, side effects and the reconstitution math in one place. No account. Nothing sold. Educational only.
Get Pepathary